Compound information
- Natural Products
- ZC353676
- Molecular Formula
- C15H21N3O3S
- Molecular Weight
- 323.130362532 g/mol
- Structure
-
- IUPAC Name
- N-[4-(4-ethylpiperazin-1-yl)sulfonylphenyl]prop-2-enamide
- InChI
- InChI=1S/C15H21N3O3S/c1-3-15(19)16-13-5-7-14(8-6-13)22(20,21)18-11-9-17(4-2)10-12-18/h3,5-8H,1,4,9-12H2,2H3,(H,16,19)
- InChI Key
- VLTYRZFLGULSGO-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(S(=O)(=O)N2CCN(CC)CC2)cc1
- Source
- ZINC000117368640
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 69.72 Å2 | LogP | 1.234 |
LogS | -2.277 | LogD | 1.604 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.005 | Pgp substrate | 0.976 |
HIA | 0.967 | F20 % | 0.993 |
F30 % | 0.847 | Caco-2 | -4.583 |
MDCK | -4.851 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.703 | PPB | 73.364 |
VD | 1.084 | Fu | 0.318 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.005 | CYP1A2 substrate | 0.678 |
CYP2A6 substrate | 0.616 | CYP2B6 substrate | 0.624 |
CYP2C19 inhibitor | 0.06 | CYP2C19 substrate | 0.81 |
CYP2C8 substrate | 0.807 | CYP2C9 inhibitor | 0.017 |
CYP2C9 substrate | 0.991 | CYP2D6 inhibitor | 0.045 |
CYP2D6 substrate | 0.946 | CYP2E1 substrate | 0.613 |
CYP3A4 inhibitor | 0.002 | CYP3A4 substrate | 0.947 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.147 | CL | 10.783 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.246 | Hepatotoxicity | 0.319 |
Mutagenicity | 0.018 | Rat Oral Acute Toxicity | 0.168 |
FDAMDD | 0.351 | Skin Sensitization | 0.768 |
Carcinogenicity | 0.03 | Eye Corrosion | 0.018 |
Eye Irritation | 0.126 | Respiratory Toxicity | 0.243 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.367 | IGC50 | 3.039 |
LC50FM | 1.625 | LC50DM | 0.668 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.196 | NR-AR-LBD | 0.351 |
NR-AhR | 0.036 | NR-Aromatase | 0.069 |
NR-ER | 0.146 | NR-ER-LBD | 0.372 |
NR-PPAR-gamma | 0.243 | SR-ARE | 0.866 |
SR-ATAD5 | 0.361 | SR-HSE | 0.085 |
SR-MMP | 0.018 | SR-p53 | 0.057 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.